Relation of statin use and bone loss: A prospective population-based cohort study in early postmenopausal women

Osteoporosis International

Volumn 13, Issue 7, 2002, Pages 537-541

  Sirola, J ^a,b   Honkanen, R ^a   Kroger H ^b   Jurvelin, J S ^b   Maenpaa P ^c   Saarikoski, S ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Department of Surgery ^*  (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Bone loss; Osteoporosis; Postmenopausal women; Prospective study; Statins

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FINLAND; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POPULATION RESEARCH; POSTMENOPAUSE; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANTICHOLESTEREMIC AGENTS; BONE DENSITY; COHORT STUDIES; DENSITOMETRY, X-RAY; FEMALE; FINLAND; HIP; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PROSPECTIVE STUDIES;

EID: 0036063969     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001980200070     Document Type: Article

References (15)

1. How many women have osteoporosis now?
2. Stimulation of bone formation in vitro and in rodents by statins
3. HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients
4. Oral statins and increased bone-mineral density in postmenopausal women
5. Statin use, bone mass and fracture: An analysis of two prospective studies
6. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women
7. HMG-CoA reductase inhibitors and the risk of fractures
8. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients
9. Lipid clearing agents in steroid-induced osteoporosis
10. The Otto Aufranc award: Lovastatin prevents steroid induced adipogenesis and osteonecrosis
11. Cholesterol lowering drugs may boost bones
12. The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: A clue to the mechanism of action of nitrogen-containing bisphosphonates
13. Bone mineral density and risk factors for osteoporosis: A population-based study of 1600 perimenopausal women
14. Dual-energy X-ray absorptiometry in normal women: A cross-sectional study of 717 Finnish volunteers
15. Bone loss, physical activity, and weight change in elderly women: The Dubbo Osteoporosis Epidemiology Study